• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼部表现与慢性眼移植物抗宿主病中泪液淋巴毒素-α水平降低有关。

Ophthalmic manifestations are associated with reduced tear lymphotoxin-α levels in chronic ocular graft-versus-host disease.

机构信息

Department of Ophthalmology, Peking University Third Hospital, No.49 Garden North Road, Haidian, Beijing, 100191, China.

Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing, China.

出版信息

BMC Ophthalmol. 2022 Jan 10;22(1):18. doi: 10.1186/s12886-022-02251-y.

DOI:10.1186/s12886-022-02251-y
PMID:35012541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8751380/
Abstract

PURPOSE

To determine the role tear lymphotoxin-α (LT-α) in chronic ocular graft-versus-host disease (oGVHD).

METHODS

Twenty-two chronic oGVHD and 17 control tear samples were collected, and commercial test strips were used to detect LT-α concentrations. Concentration differences between patients with and without oGVHD were determined via Mann-Whitney U test. The correlation between LT-α levels and ophthalmic parameters was analyzed using Spearman's test.

RESULTS

The concentration of LT-α was significantly lower in oGVHD patients than in controls. LT-α levels were significantly correlated with OSDI, NIH eye score, T-BUT, and CFS among all participants. ROC analysis revealed that the area under the curve of LT-α was 0.847, and the cutoff value for chronic oGVHD diagnosis was 0.203 ng/mL.

CONCLUSION

Our study revealed the significant decrease of tear LT-α in oGVHD, and suggested LT-α as a promising marker for chronic oGVHD diagnosis.

摘要

目的

确定泪液淋巴毒素-α(LT-α)在慢性眼移植物抗宿主病(oGVHD)中的作用。

方法

收集 22 例慢性 oGVHD 和 17 例对照的泪液样本,并使用商业检测条检测 LT-α浓度。通过 Mann-Whitney U 检验确定 oGVHD 患者和无 oGVHD 患者之间的浓度差异。使用 Spearman 检验分析 LT-α 水平与眼科参数之间的相关性。

结果

oGVHD 患者的 LT-α 浓度明显低于对照组。在所有参与者中,LT-α 水平与 OSDI、NIH 眼评分、T-BUT 和 CFS 均呈显著相关。ROC 分析显示,LT-α 的曲线下面积为 0.847,慢性 oGVHD 诊断的截断值为 0.203ng/mL。

结论

本研究揭示了 oGVHD 患者泪液 LT-α 的显著降低,并提示 LT-α 可能成为诊断慢性 oGVHD 的有前途的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8272/8751380/4fa9b657a857/12886_2022_2251_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8272/8751380/173fe973a077/12886_2022_2251_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8272/8751380/4fa9b657a857/12886_2022_2251_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8272/8751380/173fe973a077/12886_2022_2251_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8272/8751380/4fa9b657a857/12886_2022_2251_Fig2_HTML.jpg

相似文献

1
Ophthalmic manifestations are associated with reduced tear lymphotoxin-α levels in chronic ocular graft-versus-host disease.眼部表现与慢性眼移植物抗宿主病中泪液淋巴毒素-α水平降低有关。
BMC Ophthalmol. 2022 Jan 10;22(1):18. doi: 10.1186/s12886-022-02251-y.
2
Tear Film Immunological Profile in Patients with Ocular Graft versus Host Disease.眼移植物抗宿主病患者的泪膜免疫特征。
Ocul Immunol Inflamm. 2023 May;31(4):701-709. doi: 10.1080/09273948.2022.2046794. Epub 2022 Apr 11.
3
Biomarkers in Ocular Graft-Versus-Host Disease: Implications for the Involvement of B Cells.眼移植物抗宿主病的生物标志物:B 细胞参与的意义。
Transplant Cell Ther. 2022 Nov;28(11):749.e1-749.e7. doi: 10.1016/j.jtct.2022.07.023. Epub 2022 Jul 29.
4
Tear Lipid Metabolites As Potential Diagnostic Biomarkers for Ocular Chronic Graft-Versus-Host Disease.泪液脂质代谢物作为眼部慢性移植物抗宿主病的潜在诊断生物标志物。
Transplant Cell Ther. 2021 Mar;27(3):232.e1-232.e6. doi: 10.1016/j.jtct.2020.12.018. Epub 2020 Dec 19.
5
Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD).眼慢性移植物抗宿主病(GVHD)的诊断和严重程度评估中的泪液细胞因子水平。
Ocul Surf. 2020 Apr;18(2):298-304. doi: 10.1016/j.jtos.2019.12.005. Epub 2020 Jan 15.
6
Tear Cytokines Associated With Therapeutic Effects in Chronic Ocular Graft-Versus-Host Disease.与慢性眼部移植物抗宿主病治疗效果相关的泪液细胞因子
Cornea. 2023 Feb 1;42(2):211-216. doi: 10.1097/ICO.0000000000003081. Epub 2022 Jul 4.
7
Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease.硅酮泪点塞治疗伴或不伴眼移植物抗宿主病患者干眼的疗效和保留率。
Ocul Surf. 2020 Oct;18(4):731-735. doi: 10.1016/j.jtos.2020.07.018. Epub 2020 Jul 30.
8
Corneal biomechanical alterations in patients with chronic ocular Graft Versus-Host Disease.慢性眼部移植物抗宿主病患者的角膜生物力学改变。
PLoS One. 2019 Apr 25;14(4):e0213117. doi: 10.1371/journal.pone.0213117. eCollection 2019.
9
Tear Proteomic Predictive Biomarker Model for Ocular Graft Versus Host Disease Classification.用于眼部移植物抗宿主病分类的泪液蛋白质组学预测生物标志物模型
Transl Vis Sci Technol. 2020 Aug 3;9(9):3. doi: 10.1167/tvst.9.9.3. eCollection 2020 Aug.
10
Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Patients With Dry Eye Disease Associated With Ocular Graft-Versus-Host Disease.5% 利非司特滴眼液治疗与眼部移植物抗宿主病相关的干眼症患者的疗效和安全性
Cureus. 2024 Aug 8;16(8):e66437. doi: 10.7759/cureus.66437. eCollection 2024 Aug.

引用本文的文献

1
A protocol for a single center, randomized, controlled trial assessing the effects of spectacles or orthokeratology on dry eye parameters in children and adolescents.一项单中心、随机、对照试验的方案,评估眼镜或角膜塑形术对儿童和青少年干眼参数的影响。
Heliyon. 2024 Sep 12;10(18):e37779. doi: 10.1016/j.heliyon.2024.e37779. eCollection 2024 Sep 30.
2
Molecular Biomarkers in Ocular Graft-versus-Host Disease: A Systematic Review.眼移植物抗宿主病的分子生物标志物:系统评价。
Biomolecules. 2024 Jan 12;14(1):102. doi: 10.3390/biom14010102.
3
Role of lymphotoxin alpha as a new molecular biomarker in revolutionizing tear diagnostic testing for dry eye disease.

本文引用的文献

1
Tear Lipid Metabolites As Potential Diagnostic Biomarkers for Ocular Chronic Graft-Versus-Host Disease.泪液脂质代谢物作为眼部慢性移植物抗宿主病的潜在诊断生物标志物。
Transplant Cell Ther. 2021 Mar;27(3):232.e1-232.e6. doi: 10.1016/j.jtct.2020.12.018. Epub 2020 Dec 19.
2
Evaluation of Tear Protein Markers in Dry Eye Disease with Different Lymphotoxin-Alpha Expression Levels.评估不同淋巴毒素-α表达水平的干眼疾病的泪蛋白标志物。
Am J Ophthalmol. 2020 Sep;217:198-211. doi: 10.1016/j.ajo.2020.03.013. Epub 2020 Mar 21.
3
Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD).
淋巴毒素α作为一种新型分子生物标志物在革新干眼症泪液诊断检测中的作用。
Int J Ophthalmol. 2023 Nov 18;16(11):1883-1889. doi: 10.18240/ijo.2023.11.22. eCollection 2023.
4
Exploration of efficacy and mechanism of 0.05% cyclosporine eye drops (II) monotherapy in allergic conjunctivitis-associated dry eye.0.05%环孢素滴眼液(II)单药治疗过敏性结膜炎相关干眼的疗效及机制探讨。
Eye (Lond). 2024 Apr;38(5):937-944. doi: 10.1038/s41433-023-02807-2. Epub 2023 Oct 30.
5
Recent advances in ocular graft-versus-host disease.眼移植物抗宿主病的最新进展。
Front Immunol. 2023 Jan 25;14:1092108. doi: 10.3389/fimmu.2023.1092108. eCollection 2023.
眼慢性移植物抗宿主病(GVHD)的诊断和严重程度评估中的泪液细胞因子水平。
Ocul Surf. 2020 Apr;18(2):298-304. doi: 10.1016/j.jtos.2019.12.005. Epub 2020 Jan 15.
4
The role of lymphotoxin-α in rheumatoid arthritis.淋巴毒素-α 在类风湿关节炎中的作用。
Inflamm Res. 2018 Jun;67(6):495-501. doi: 10.1007/s00011-018-1139-6. Epub 2018 Mar 14.
5
Hematopoietic stem cell transplantation for acute myeloid leukemia: A review.急性髓系白血病的造血干细胞移植:综述
Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):245-251. doi: 10.1016/j.hemonc.2017.05.021. Epub 2017 Jun 20.
6
Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model.眼部慢性移植物抗宿主病中的生物标志物:基于泪液细胞因子和趋化因子的预测模型。
Invest Ophthalmol Vis Sci. 2016 Feb;57(2):746-58. doi: 10.1167/iovs.15-18615.
7
Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease.泪液细胞因子作为慢性移植物抗宿主病的生物标志物
Biol Blood Marrow Transplant. 2015 Dec;21(12):2079-2085. doi: 10.1016/j.bbmt.2015.08.020. Epub 2015 Aug 22.
8
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识发展项目:I. 2014年诊断与分期工作组报告
Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1. doi: 10.1016/j.bbmt.2014.12.001. Epub 2014 Dec 18.
9
Lymphotoxin and TNF: how it all began-a tribute to the travelers.淋巴毒素和 TNF:一切是如何开始的——向旅行者致敬。
Cytokine Growth Factor Rev. 2014 Apr;25(2):83-9. doi: 10.1016/j.cytogfr.2014.02.001. Epub 2014 Feb 12.
10
Ocular graft-versus-host disease: a review.眼移植物抗宿主病:综述。
Surv Ophthalmol. 2013 May-Jun;58(3):233-51. doi: 10.1016/j.survophthal.2012.08.004. Epub 2013 Mar 27.